Published in Br Heart J on June 01, 1982
QT interval as a cardiac risk factor in a middle aged population. Heart (1997) 1.06
Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart. J Physiol (1984) 0.99
The prolonged QT interval--a frequently unrecognized abnormality. Postgrad Med J (1985) 0.97
Acute effects of amiodarone upon the canine sinus node and atrioventricular junctional region. J Clin Invest (1983) 0.81
Interactions of beta-adrenoceptor antagonists and thyroid hormones in the control of heart rate in the dog. Br J Pharmacol (1985) 0.75
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
A NEW FAMILIAL CARDIAC SYNDROME IN CHILDREN. J Ir Med Assoc (1964) 3.94
[RARE CARDIAC ARRYTHMIAS OF THE PEDIATRIC AGE. II. SYNCOPAL ATTACKS DUE TO PAROXYSMAL VENTRICULAR FIBRILLATION. (PRESENTATION OF 1ST CASE IN ITALIAN PEDIATRIC LITERATURE)]. Clin Pediatr (Bologna) (1963) 3.59
QT interval prolongation as predictor of sudden death in patients with myocardial infarction. Circulation (1978) 3.32
A COMPARISON OF THE ANTIFIBRILLATORY ACTIONS AND EFFECTS ON INTRACELLULAR CARDIAC POTENTIALS OF PRONETHALOL, DISOPYRAMIDE AND QUINIDINE. Br J Pharmacol Chemother (1963) 2.24
Effect of intravenous propranolol on QT interval. A new method of assessment. Br Heart J (1980) 1.71
Class 3 antiarrhythmic action in man. Observations from monophasic action potential recordings and amiodarone treatment. Br Heart J (1973) 1.60
The effects of amiodarone, an alpha and beta receptor antiagonist, on adrenergic transmission in the cat spleen. Biochem Pharmacol (1976) 1.55
Cardiac actions in the dog of a new antagonist of adrenergic excitation which does not produce competitive blockade of adrenoceptors. Br J Pharmacol (1970) 1.47
Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment. Br Heart J (1981) 1.46
Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia. Br J Pharmacol (1982) 1.13
Effects of acute and chronic beta-receptor blockade on ventricular repolarisation in man. Br Heart J (1981) 1.07
[Research on the benzofuran series. XL. Anti-arrhythmic properties of amiodarone]. Cardiologia (1969) 1.06
[Medical therapy of auricular flutter]. G Ital Cardiol (1972) 0.88
The effect of prolonged propranolol administration on myocardial transmural capillary density in young rabbits. J Physiol (1981) 0.84
The effect of amiodarone, a new anti-anginal drug, on cardiac muscle. Br J Pharmacol (1970) 5.24
The relevance of beta-receptor blockade to ouabain-induced cardiac arrhythmias. Br J Pharmacol (1969) 3.26
A third class of anti-arrhythmic action. Effects on atrial and ventricular intracellular potentials, and other pharmacological actions on cardiac muscle, of MJ 1999 and AH 3474. Br J Pharmacol (1970) 2.78
A classification of antiarrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol (1984) 2.63
Dual effect of disopyramide on atrial and atrioventricular conduction and refractory periods. Br Heart J (1977) 1.94
Classification of antidysrhythmic drugs. Pharmacol Ther B (1975) 1.73
The effect of bretylium on intracellular cardiac action potentials in relation to its anti-arrhythmic and local anaesthetic activity. Br J Pharmacol (1969) 1.37
The effect of oxprenolol on cardiac intracellular potentials in relation to its anti-arrhythmic, local anaesthetic and other properties. Postgrad Med J (1970) 1.37
The multiple modes of action of propafenone. Eur Heart J (1984) 1.16
Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia. Br J Pharmacol (1982) 1.13
Electrophysiological effects of alpha-adrenoceptor antagonists in rabbit sino-atrial node, cardiac Purkinje cells and papillary muscles. Br J Pharmacol (1984) 1.10
Voltage- and time-dependent depression of maximum rate of depolarisation of guinea-pig ventricular action potentials by two new antiarrhythmic drugs, flecainide and lorcainide. Cardiovasc Res (1983) 1.08
The effect of some catecholamine beta-receptor blocking compounds on the toxicity to the heart of ouabain. Br J Pharmacol (1969) 1.06
Effects on rabbit nodal, atrial, ventricular and Purkinje cell potentials of a new antiarrhythmic drug, cibenzoline, which protects against action potential shortening in hypoxia. Br J Pharmacol (1982) 1.05
Effects of selective alpha 1-, alpha 2-, beta 1-and beta 2-adrenoceptor stimulation on potentials and contractions in the rabbit heart. J Physiol (1984) 0.99
The effects of palmitate on intracellular potentials recorded from Langendorff-erfused guinea-pig hearts in normoxia and hypoxia, and during perfusion at reduced rate of flow. J Mol Cell Cardiol (1977) 0.97
Pharmacological mapping of regional effects in the rabbit heart of some new antiarrhythmic drugs. Br J Pharmacol (1983) 0.94
Subgroups of class 1 antiarrhythmic drugs. Eur Heart J (1984) 0.93
Delayed ventricular repolarization as an anti-arrhythmic principle. Eur Heart J (1985) 0.92
Hypoxic cardiac hypertrophy is not inhibited by cardioselective or non-selective beta-adrenoceptor antagonists. J Physiol (1982) 0.88
Adaptational responses to prolonged beta-adrenoceptor blockade in adult rabbits. Br J Pharmacol (1980) 0.87
Effect of prolonged beta-adrenoceptor blockade on heart weight and ultrastructure in young rabbits. Br J Pharmacol (1980) 0.87
Electrophysiological and other effects on rabbit hearts of CCI22277, a new steroidal antiarrhythmic drug. Br J Pharmacol (1982) 0.84
Investigations of the mode of action of a new antidysrhythmic drug, Kö 1173. Br J Pharmacol (1972) 0.81
Cardiovascular effects of bevantolol, a selective beta 1-adrenoceptor antagonist with a novel pharmacological profile. Br J Pharmacol (1985) 0.81
Disopyramide. Ann N Y Acad Sci (1984) 0.81
Ventricular hypertrophy--physiological mechanisms. J Cardiovasc Pharmacol (1986) 0.79
The effects of indecainide, a new antidysrhythmic drug, on nodal tissues in the isolated rabbit heart. J Cardiovasc Pharmacol (1986) 0.78
The effect of prolonged treatment with oxyfedrine on intracellular potentials and on other features of cardiac function in rabbits and guinea-pigs. Br J Pharmacol (1973) 0.78
Diarrhoea and intestinal fluid accumulation in uninfected rabbits cross perfused with blood from donor rabbits intra-intestinally infected with cholera. Nature (1969) 0.78
Cardiac electrophysiological effects of selective adrenoceptor stimulation and their possible roles in arrhythmias. J Cardiovasc Pharmacol (1985) 0.77
Hypoxia-induced cardiac hypertrophy in rabbits treated with verapamil and nifedipine. Br J Pharmacol (1983) 0.77
Electrophysiological and cardiovascular effects of pirmenol, a new class 1 antiarrhythmic drug. J Cardiovasc Pharmacol (1986) 0.77
Heart rate and QT interval in subjects adapted to beta-blockade: bradycardia and hypotension as uncorrelated adaptations. Cardiovasc Res (1983) 0.76
Effects on rabbit cardiac potentials of aprindine and indecainide, a new antiarrhythmic agent, in normoxia and hypoxia. Br J Pharmacol (1985) 0.75
Circadian rhythm of heart rate in the rabbit: prolongation of action potential duration by sustained beta adrenoceptor blockade is not due to associated bradycardia. Cardiovasc Res (1986) 0.75
The effect of cardiac muscle of two drugs related to amiodarone, L8040 and L8462. Eur J Pharmacol (1974) 0.75
Resistance to hypoxia-induced shortening of action potential duration of hypertrophied rabbit hearts. Cardiovasc Res (1984) 0.75
Quantitative assessment of antidysrhythmic drugs. G Ital Cardiol (1972) 0.75
Central nervous system effects of beta adrenergic blocking drugs. Ann N Y Acad Sci (1967) 0.75
The experimental basis for the choice of an anti-arrhythmic drug. Adv Cardiol (1970) 0.75